Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Trends in the utilisation of COPD therapeutic regimens before and after the introduction of LAMA/LABA combination products: A population-based study.

Parkin L, Khuu W, Stanbrook MB, Tadrous M, Martins D, Gomes T.

Respir Med. 2018 Oct;143:1-7. doi: 10.1016/j.rmed.2018.08.001. Epub 2018 Aug 14.

PMID:
30261979
2.

As-needed budesonide-formoterol better controlled mild asthma vs terbutaline, but maintenance budesonide was better.

Stanbrook MB.

Ann Intern Med. 2018 Sep 18;169(6):JC31. doi: 10.7326/ACPJC-2018-169-6-031. No abstract available.

PMID:
30242404
3.

As-needed budesonide-formoterol was noninferior to maintenance budesonide for exacerbations in mild asthma.

Stanbrook MB.

Ann Intern Med. 2018 Sep 18;169(6):JC30. doi: 10.7326/ACPJC-2018-169-6-030. No abstract available.

PMID:
30242403
4.

Withdrawal of Saudi trainees exposes vulnerability of Canadian health care.

Khan MH, Abdullah N, Stanbrook MB.

CMAJ. 2018 Sep 4;190(35):E1030-E1032. doi: 10.1503/cmaj.181084. Epub 2018 Aug 21. No abstract available.

5.

In symptomatic COPD, once-daily triple vs dual therapy reduced moderate or severe exacerbations at 1 year.

Stanbrook MB.

Ann Intern Med. 2018 Aug 21;169(4):JC16. doi: 10.7326/ACPJC-2018-169-4-016. No abstract available.

PMID:
30128506
6.

Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis.

Rajchgot J, Stanbrook MB, Anand A.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1105. doi: 10.1164/rccm.201805-0954LE. No abstract available.

PMID:
30025213
7.

End of Life Strategies Among Patients with Advanced Chronic Obstructive Pulmonary Disease (COPD).

Gershon AS, Maclagan LC, Luo J, To T, Kendzerska T, Stanbrook MB, Bourbeau J, Etches J, Aaron SD.

Am J Respir Crit Care Med. 2018 Jun 11. doi: 10.1164/rccm.201803-0592OC. [Epub ahead of print]

PMID:
29889548
8.

Vitamin D supplementation to prevent asthma exacerbations.

Khan MH, Stanbrook MB, Anand A.

Lancet Respir Med. 2018 Jun;6(6):e25. doi: 10.1016/S2213-2600(18)30193-0. No abstract available.

PMID:
29856326
9.

Dual Bronchodilators and β-Blockade for Cardiovascular Risk in Chronic Obstructive Pulmonary Disease.

Zaheen A, Anand A, Stanbrook MB.

JAMA Intern Med. 2018 May 1;178(5):730-731. doi: 10.1001/jamainternmed.2018.1442. No abstract available.

PMID:
29801135
10.

In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days.

Stanbrook MB.

Ann Intern Med. 2018 Apr 17;168(8):JC47. doi: 10.7326/ACPJC-2018-168-8-047. No abstract available.

PMID:
29677254
11.

Vulnerable populations: an area CMAJ will continue to champion.

Patrick K, Flegel K, Stanbrook MB.

CMAJ. 2018 Mar 19;190(11):E307. doi: 10.1503/cmaj.180288. No abstract available.

12.

Health Services Burden of Undiagnosed and Overdiagnosed COPD.

Gershon AS, Thiruchelvam D, Chapman KR, Aaron SD, Stanbrook MB, Bourbeau J, Tan W, To T; Canadian Respiratory Research Network.

Chest. 2018 Jun;153(6):1336-1346. doi: 10.1016/j.chest.2018.01.038. Epub 2018 Feb 6.

PMID:
29425675
13.

Health services research: a special CMAJ focus.

Patrick K, Mamdani M, Stanbrook MB, Kelsall D.

CMAJ. 2017 Dec 11;189(49):E1504. doi: 10.1503/cmaj.171389. No abstract available.

14.

Azithromycin reduced exacerbations and improved QoL in symptomatic asthma despite inhaled maintenance therapy.

Stanbrook MB.

Ann Intern Med. 2017 Oct 17;167(8):JC42. doi: 10.7326/ACPJC-2017-167-8-042. No abstract available.

PMID:
29049761
15.

Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma.

Tadrous M, Khuu W, Lebovic G, Stanbrook MB, Martins D, Paterson JM, Mamdani MM, Juurlink DN, Gomes T.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):59-65.e2. doi: 10.1016/j.anai.2017.08.016. Epub 2017 Oct 3.

PMID:
28986124
16.

Tax reform plays politics with doctors' reputations.

Stanbrook MB.

CMAJ. 2017 Oct 2;189(39):E1249. doi: 10.1503/cmaj.171132. No abstract available.

17.

A 1980 Letter on the Risk of Opioid Addiction.

Leung PTM, Macdonald EM, Stanbrook MB, Dhalla IA, Juurlink DN.

N Engl J Med. 2017 Jun 1;376(22):2194-2195. doi: 10.1056/NEJMc1700150. No abstract available.

18.

Review: In COPD, injectable polyvalent pneumococcal vaccines reduce risk for community-acquired pneumonia.

Stanbrook MB.

Ann Intern Med. 2017 May 16;166(10):JC52. doi: 10.7326/ACPJC-2017-166-10-052. No abstract available.

PMID:
28505636
19.

Accidental barium bronchography.

Zaheen A, Stanbrook MB.

CMAJ. 2017 May 8;189(18):E670. doi: 10.1503/cmaj.160969. No abstract available.

20.

Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing.

Gershon A, Mecredy G, Croxford R, To T, Stanbrook MB, Aaron SD; Canadian Respiratory Research Network.

CMAJ. 2017 Apr 10;189(14):E530-E538. doi: 10.1503/cmaj.151420. Epub 2016 Nov 14.

21.

Trump travel ban means academics must strengthen, not sever, US ties.

Stanbrook MB.

CMAJ. 2017 Mar 20;189(11):E420-E421. doi: 10.1503/cmaj.170247. No abstract available.

22.

Renewal for CMAJ.

Kelsall D, Flegel K, Patrick K, Russell E, Sibbald B, Stanbrook MB.

CMAJ. 2017 Jan 9;189(1):E1. doi: 10.1503/cmaj.161478. No abstract available.

23.

Adding formoterol to budesonide did not increase serious asthma events and reduced exacerbations.

Stanbrook MB.

Ann Intern Med. 2016 Nov 15;165(10):JC56. doi: 10.7326/ACPJC-2016-165-10-056. No abstract available.

PMID:
27842393
24.

Innovation and the new health accord.

Stanbrook MB.

CMAJ. 2016 Dec 6;188(17-18):1207. Epub 2016 Oct 31. No abstract available.

25.

Mycophenolate mofetil for scleroderma-related interstitial lung disease.

Zaheen A, Stanbrook MB, Anand A.

Lancet Respir Med. 2016 Nov;4(11):e53. doi: 10.1016/S2213-2600(16)30318-6. No abstract available.

PMID:
27799132
26.

Canada Health Act needs bite.

Sibbald B, Stanbrook MB.

CMAJ. 2016 Nov 1;188(16):1133. No abstract available.

27.

Why CMAJ writes editorials.

Kelsall D, Stanbrook MB, Flegel K, Patrick K, Russell E, Sibbald B.

CMAJ. 2016 Sep 6;188(12):850. doi: 10.1503/cmaj.160878. Epub 2016 Aug 8. No abstract available.

28.

Electronic cigarettes and youth: a gateway that must be shut.

Stanbrook MB.

CMAJ. 2016 Aug 9;188(11):785. doi: 10.1503/cmaj.160728. Epub 2016 Jul 18. No abstract available.

29.

Factors associated with undiagnosed and overdiagnosed COPD.

Gershon AS, Hwee J, Chapman KR, Aaron SD, O'Donnell DE, Stanbrook MB, Bourbeau J, Tan W, Su J, Victor JC, To T.

Eur Respir J. 2016 Aug;48(2):561-4. doi: 10.1183/13993003.00458-2016. Epub 2016 Jun 23. No abstract available.

30.

Why Canada needs CMAJ.

Kelsall D, Stanbrook MB, Patrick K, Flegel K, Russell E, Sibbald B.

CMAJ. 2016 Jun 14;188(9):637. doi: 10.1503/cmaj.160539. Epub 2016 May 24. No abstract available.

31.

Upholding the integrity of your CMAJ.

Kelsall D, Patrick K, Stanbrook MB, Sibbald B, Flegel K, Russell E, Deshauer D, Holroyd-Leduc JM, Kastner M, Straus S, Wells G, Walji M.

CMAJ. 2016 Apr 5;188(6):E113-4. doi: 10.1503/cmaj.160283. Epub 2016 Mar 7. No abstract available.

32.

Review: Combination umeclidinium/vilanterol improved health status more than umeclidinium in COPD.

Stanbrook MB.

Ann Intern Med. 2015 Dec 15;163(12):JC10. doi: 10.7326/ACPJC-2015-163-12-010. No abstract available.

PMID:
26666800
33.

A letter to our colleague, Canada's new Minister of Health.

Stanbrook MB, Flegel K, Kelsall D, Patrick K, Russell E, Fletcher J.

CMAJ. 2016 Jan 5;188(1):9. doi: 10.1503/cmaj.151398. Epub 2015 Dec 7. No abstract available.

34.

Review: Influenza vaccination and inhaled therapies prevent acute exacerbations in COPD.

Stanbrook MB.

Ann Intern Med. 2015 Sep 15;163(6):JC3. doi: 10.7326/ACPJC-2015-163-6-003. No abstract available.

PMID:
26370030
35.

Why the federal government must lead in health care.

Stanbrook MB.

CMAJ. 2015 Sep 8;187(12):858. doi: 10.1503/cmaj.150896. Epub 2015 Aug 17. No abstract available.

36.

Socioeconomic Status, Sex, Age and Access to Medications for COPD in Ontario, Canada.

Gershon A, Campitelli MA, Hwee J, Croxford R, To T, Stanbrook MB, Upshur R, Stephenson A, Stukel TA.

COPD. 2015;12(6):668-79. doi: 10.3109/15412555.2015.1020148.

PMID:
26244774
37.

Quality of asthma care under different primary care models in Canada: a population-based study.

To T, Guan J, Zhu J, Lougheed MD, Kaplan A, Tamari I, Stanbrook MB, Simatovic J, Feldman L, Gershon AS.

BMC Fam Pract. 2015 Feb 14;16:19. doi: 10.1186/s12875-015-0232-y.

38.

Health professionalism must be ensured online and offline.

Walji M, Stanbrook MB.

CMAJ. 2015 May 19;187(8):547. doi: 10.1503/cmaj.150248. Epub 2015 Apr 7. No abstract available.

39.

Canada can afford universal pharmacare – no more excuses.

Stanbrook MB.

CMAJ. 2015 Apr 21;187(7):475. doi: 10.1503/cmaj.150281. Epub 2015 Mar 23. No abstract available.

40.

ACP journal club. For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation.

Stanbrook MB.

Ann Intern Med. 2015 Mar 17;162(6):JC5. doi: 10.7326/ACPJC-2015-162-6-005. No abstract available.

PMID:
25775348
41.

Long-acting β-agonists with vs without inhaled corticosteroids for COPD--reply.

Gershon AS, Campitelli MA, Stanbrook MB.

JAMA. 2015 Jan 20;313(3):305-6. doi: 10.1001/jama.2014.16479. No abstract available.

PMID:
25603005
42.

Caring for Aboriginal patients requires trust and respect, not courtrooms.

Richardson L, Stanbrook MB.

CMAJ. 2015 Feb 17;187(3):162. doi: 10.1503/cmaj.141613. Epub 2015 Jan 19. No abstract available.

43.

Canada must help the wounded children of Gaza.

Stanbrook MB.

CMAJ. 2014 Oct 21;186(15):1123. doi: 10.1503/cmaj.141164. Epub 2014 Sep 22. No abstract available.

44.

Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.

Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA.

JAMA. 2014 Sep 17;312(11):1114-21. doi: 10.1001/jama.2014.11432.

PMID:
25226477
45.

ACP Journal Club. Review: In COPD, fluticasone or budesonide increases serious pneumonia but not mortality.

Stanbrook MB.

Ann Intern Med. 2014 Aug 19;161(4):JC8. doi: 10.7326/0003-4819-161-4-201408190-02008. No abstract available.

PMID:
25133387
46.

Does this patient have an exudative pleural effusion? The Rational Clinical Examination systematic review.

Wilcox ME, Chong CA, Stanbrook MB, Tricco AC, Wong C, Straus SE.

JAMA. 2014 Jun 18;311(23):2422-31. doi: 10.1001/jama.2014.5552. Review.

PMID:
24938565
47.

Bronchodilator safety in chronic obstructive pulmonary disease-reply.

Stanbrook MB, Campitelli M, Gershon A.

JAMA Intern Med. 2014 Apr;174(4):648. doi: 10.1001/jamainternmed.2013.12684. No abstract available.

PMID:
24711200
48.

Stopping cyberbullying requires a combined societal effort.

Stanbrook MB.

CMAJ. 2014 Apr 15;186(7):483. doi: 10.1503/cmaj.140299. Epub 2014 Mar 24. No abstract available.

49.

Canada owes refugees adequate health coverage.

Stanbrook MB.

CMAJ. 2014 Feb 4;186(2):91. doi: 10.1503/cmaj.131861. Epub 2014 Jan 20. No abstract available.

50.

ACP Journal Club. Mandibular advancement device and CPAP did not differ for health outcomes in obstructive sleep apnea.

Stanbrook MB.

Ann Intern Med. 2013 Oct 15;159(8):JC10. doi: 10.7326/0003-4819-159-8-201310150-02010. No abstract available.

PMID:
24126659

Supplemental Content

Loading ...
Support Center